Shirley Kuhlmann serves as the Executive Vice President, Chief Administrative Officer, General Counsel & Secretary at Collegium Pharmaceutical Inc., a specialty pharmaceutical company focused on developing and commercializing innovative treatments for pain management. In her multifaceted role, Kuhlmann is responsible for overseeing the company's legal affairs, corporate governance, compliance, and various administrative functions. Her leadership has been instrumental in guiding Collegium through complex regulatory environments and ensuring the company's strategic initiatives align with its mission to improve patient care. Before joining Collegium Pharmaceutical, Kuhlmann built an impressive career in the legal and pharmaceutical industries. She holds a Juris Doctor degree from a top-tier law school and has extensive experience in corporate law, with a particular focus on healthcare and pharmaceuticals. Prior to her current position, she held senior legal roles at several prominent pharmaceutical companies, where she played key roles in major transactions, including mergers and acquisitions, and navigated intricate regulatory landscapes. Her expertise in these areas has been crucial in helping Collegium Pharmaceutical navigate the challenges of bringing new pain management solutions to market. Under Kuhlmann's guidance, Collegium Pharmaceutical has achieved significant milestones, including the successful launch and commercialization of several products that have made a meaningful impact on patients' lives. Her strategic vision and dedication to excellence have earned her recognition within the industry and among her peers. As a leader at Collegium, Kuhlmann continues to drive the company forward, ensuring it remains at the forefront of innovation in pain management while maintaining the highest standards of corporate responsibility and ethical conduct.